XERS

XERIS BIOPHARMA HOLDINGS INC

XERS·98422E103·US·Common Stock·Healthcare - Biotechnology-13D/G

XERS (XERIS BIOPHARMA HOLDINGS INC) is held by 121 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($75.1M), D. E. Shaw & Co., Inc. ($45.2M), STATE STREET CORP ($27M). Net institutional sentiment: Mixed.

121
Holders
(9 Elite)
$430.6M
Total Value
66% (122)
Consensus
80 buying - 42 selling
13F: Insider & Congress:
XERS

Smart Money Verdict

View all
Held by 121 funds
9 elite

Who's Trading

InsiderPSPieper StevenSell $235KJul 7, 2026
InsiderPSPieper StevenSell $148KJul 6, 2026
InsiderMKMcCulloch KevinSell $723KJul 1, 2026
InsiderPMPERSKY MARLASell $91KJun 3, 2026
InsiderHBHecht BethSell $104KMay 1, 2026
InsiderHBHecht BethSell $100KApr 1, 2026
InsiderBABrady James AloysiusSell $60KMar 30, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderHBHecht BethSell $103KMar 2, 2026
InsiderHBHecht BethSell $706Mar 2, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
12.9M(+2.4%)$75.1M0.0%+115.26%
30
Increased
7.8M(+2.8%)$45.2M0.0%+38.13%
30
Increased
4.7M(+13.2%)$27M0.0%+144.35%
32
Increased
4.3M(+0.3%)$24.9M0.0%+170.21%
29
Increased
4.1M(+17.6%)$23.9M0.0%+57.52%
33
Increased
2.9M(+3.9%)$16.9M0.0%+46.93%
29
Decreased
2.6M(-5.0%)$14.9M0.0%+132.25%
0
Increased
2.3M(+163.8%)$13.1M0.0%+50.32%
45
Decreased
2.2M(-5.0%)$12.6M0.0%+28.29%
0
Increased
1.9M(+11.1%)$11.2M0.0%+36.87%
31
Increased
1.9M(+36.7%)$11.1M0.0%+56.61%
36
Increased
1.6M(+173.6%)$9.5M0.0%+28.40%
45
Increased
1.6M(+2.9%)$9.4M0.0%+90.80%
28
Increased
1.4M(+4.2%)$8.4M0.0%+226.28%
29
Increased
1.4M(+45.6%)$8.1M0.0%+119.58%
37
Decreased
1.4M(-3.1%)$7.9M0.0%+40.88%
0
Decreased
902,740(-69.7%)$5.2M0.0%+48.50%
0
Increased
874,397(+21.8%)$5.1M0.0%+81.44%
32
Increased
856,813(+0.2%)$5M0.0%+41.02%
27
Increased
833,217(+290.1%)$4.8M0.0%+28.53%
43

Showing 1-20 of 128

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used